Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Chemotherapy (Ifosfamide, Carboplatin, Doxorubicin) for Osteosarcoma
NCT00145639Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- May 1999
- Primary completion
- May 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of doxorubicin in osteosarcoma (OS), sponsored by St. Jude Children's Research Hospital. Primary endpoint: Histologic response rate at Week 12. Started May 1999; status: completed.
02
Drugs
doxorubicin
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT00145639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145639.